Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Cost cuts are coming for Allergan, CEO Brent Saunders says
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5959934"]This is where you are mistaken. He hasn't extracted value from Restasis. Everything was already in place regarding Restasis. The product was already almost at a billion dollars in sales before he became CEO. The patent extensions were already in place before he became CEO. The registrations in Europe were already planned before he became CEO. He has simply followed the course that was already in place regarding Restasis.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5959934"]This is where you are mistaken. He hasn't extracted value from Restasis. Everything was already in place regarding Restasis. The product was already almost at a billion dollars in sales before he became CEO. The patent extensions were already in place before he became CEO. The registrations in Europe were already planned before he became CEO. He has simply followed the course that was already in place regarding Restasis.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Cost cuts are coming for Allergan, CEO Brent Saunders says
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Cost cuts are coming for Allergan, CEO Brent Saunders says
>